NATALIE POHL: Open Payments
NPI 1356890347 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 4 payments from 2 companies in 2025. Trend: 2023 $64 · 2024 $35 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $184 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: Descovy, ABILIFY ASIMTUFII.
Industry payments across DC — which companies pay providers there.
